LATISSE
LATISSE
Approved
DIN Number
02350939
Drug Class
Human
Market Date
Nov 1, 2010
Company
HC
Abbvie Corporation
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02350939
AIG Number0147303001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
S01EE03 BIMATOPROST
Product Specifications
Dosage FormSolution
Route of AdministrationTopical
AHFS Classification52:40.28
Health Canada Classification
ACTIVE INGREDIENTS (1)
BIMATOPROSTActive
Strength: 0.03 % / W/V
Monograph: BIMATOPROST